DE60030107D1 - Vitamin-d derivate zur behandlung des systemischen lupus erythematodes - Google Patents
Vitamin-d derivate zur behandlung des systemischen lupus erythematodesInfo
- Publication number
- DE60030107D1 DE60030107D1 DE60030107T DE60030107T DE60030107D1 DE 60030107 D1 DE60030107 D1 DE 60030107D1 DE 60030107 T DE60030107 T DE 60030107T DE 60030107 T DE60030107 T DE 60030107T DE 60030107 D1 DE60030107 D1 DE 60030107D1
- Authority
- DE
- Germany
- Prior art keywords
- vitamin
- derivatives
- treatment
- systemic lupus
- lupus erythematodes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US301970 | 1989-01-26 | ||
US30197099A | 1999-04-29 | 1999-04-29 | |
US09/422,571 US6673782B2 (en) | 1999-04-29 | 1999-10-21 | Treatment of systemic lupus erythematosis |
US422571 | 1999-10-21 | ||
PCT/US2000/011104 WO2000066098A2 (en) | 1999-04-29 | 2000-04-25 | Vitamin d derivatives for the treatment of systemic lupus erythematosus |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60030107D1 true DE60030107D1 (de) | 2006-09-28 |
DE60030107T2 DE60030107T2 (de) | 2007-04-19 |
Family
ID=26972694
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60030107T Expired - Lifetime DE60030107T2 (de) | 1999-04-29 | 2000-04-25 | Vitamin-d derivate zur behandlung des systemischen lupus erythematodes |
Country Status (9)
Country | Link |
---|---|
US (2) | US6673782B2 (de) |
EP (1) | EP1181020B1 (de) |
JP (1) | JP2002543115A (de) |
AT (1) | ATE336253T1 (de) |
AU (1) | AU4370900A (de) |
CA (1) | CA2370230C (de) |
DE (1) | DE60030107T2 (de) |
ES (1) | ES2270825T3 (de) |
WO (1) | WO2000066098A2 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6479474B2 (en) * | 1999-07-08 | 2002-11-12 | Wisconsin Alumni Research Foundation | Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis |
WO2004091573A1 (en) * | 2003-03-04 | 2004-10-28 | Teva Pharmaceutical Industries, Ltd. | Combination therapy with glatiramer acetate and alphacalcidol for the treatment of multiple sclerosis |
CA2535185C (en) * | 2003-08-20 | 2013-04-23 | Wisconsin Alumni Research Foundation | 2-methylene-19-nor-vitamin d2 compounds |
WO2006086661A2 (en) * | 2005-02-10 | 2006-08-17 | Above Sea Level, Llc | Lead generation method and system |
AU2006213722B2 (en) * | 2005-02-11 | 2011-09-22 | Wisconsin Alumni Research Foundation | 2-methylene-19-nor-(20S-24epi)-1alpha,25-dihydroxyvitamin-D2 |
EP1853274B1 (de) * | 2005-02-11 | 2013-01-23 | Wisconsin Alumni Research Foundation | 2-methylen-19-nor- (20s-24s) - 1alpha, 25-dihydroxyvitamin-d2 |
CA2758698C (en) * | 2009-04-17 | 2017-08-08 | Vidasym, Llc | Vitamin d receptor agonists and uses thereof |
US20110034426A1 (en) * | 2009-08-03 | 2011-02-10 | Wisconsin Alumni Research Foundation | Method of Preventing Renal Disease and Treating Symptoms Thereof |
MX2015000076A (es) | 2012-06-29 | 2015-04-10 | Wisconsin Alumni Reasearch Foundation | Uso de 2-metileno-19-nor- (20s) -1a, 25-dihidroxivitamina d3 para tratar el hiperparatiroidismo secundario. |
US9539264B2 (en) | 2014-12-30 | 2017-01-10 | Wisconsin Alumni Research Foundation | Use of 2-methylene-19-nor-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat secondary hyperparathyroidism in patients previously treated with calcimimetics |
US10369161B2 (en) | 2014-12-30 | 2019-08-06 | Wisconsin Alumni Research Foundation | Use of 2-methylene-19-NOR-(20S)-1-alpha,25-dihydroxyvitamin D3 to treat primary hyperparathyroidism |
US11480568B2 (en) * | 2017-09-28 | 2022-10-25 | Yeda Research And Development Co. Ltd. | Diagnosis of autoimmune diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5891865A (en) | 1996-10-04 | 1999-04-06 | Wisconsin Alumni Research Foundation | Treatment of arthritic disease induced by infectious agents |
US6030962A (en) * | 1997-04-28 | 2000-02-29 | Synttex (U.S.A.) Inc. | Vitamin D3 analogs with bis C-20 side chains |
-
1999
- 1999-10-21 US US09/422,571 patent/US6673782B2/en not_active Expired - Fee Related
-
2000
- 2000-04-25 JP JP2000614983A patent/JP2002543115A/ja active Pending
- 2000-04-25 ES ES00923617T patent/ES2270825T3/es not_active Expired - Lifetime
- 2000-04-25 CA CA002370230A patent/CA2370230C/en not_active Expired - Fee Related
- 2000-04-25 EP EP00923617A patent/EP1181020B1/de not_active Expired - Lifetime
- 2000-04-25 AU AU43709/00A patent/AU4370900A/en not_active Abandoned
- 2000-04-25 AT AT00923617T patent/ATE336253T1/de not_active IP Right Cessation
- 2000-04-25 DE DE60030107T patent/DE60030107T2/de not_active Expired - Lifetime
- 2000-04-25 WO PCT/US2000/011104 patent/WO2000066098A2/en active IP Right Grant
-
2004
- 2004-01-05 US US10/751,802 patent/US20040142912A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2000066098A3 (en) | 2001-05-31 |
CA2370230A1 (en) | 2000-11-09 |
ATE336253T1 (de) | 2006-09-15 |
EP1181020A2 (de) | 2002-02-27 |
CA2370230C (en) | 2009-12-08 |
US20020028830A1 (en) | 2002-03-07 |
AU4370900A (en) | 2000-11-17 |
US20040142912A1 (en) | 2004-07-22 |
EP1181020B1 (de) | 2006-08-16 |
ES2270825T3 (es) | 2007-04-16 |
WO2000066098A2 (en) | 2000-11-09 |
DE60030107T2 (de) | 2007-04-19 |
JP2002543115A (ja) | 2002-12-17 |
US6673782B2 (en) | 2004-01-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PT880350E (pt) | Tratamento de esclerose multipla | |
DE60316779D1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
IL172705A0 (en) | Use of [3.2.0] heterocyclic compounds and analogs thereof for the treatment of cancer, inflammation and infectious diseases | |
BR0212252A (pt) | Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero | |
AU5584901A (en) | Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease | |
ATE265213T1 (de) | Noribogain zur behandlung von schmerzen und drogenabhängigkeit | |
DE60213386D1 (de) | Geldanamycinderivate zur krebsbehandlung | |
ATE207352T1 (de) | Nicht-allosterische gaba a agonisten zur behandlung von schlafstörungen | |
WO2000045801A3 (en) | Use of a nitrate vasodilator alone or in combination with capsaicin for the treatment of pain | |
CY1109242T1 (el) | Θεραπευτικοι παραγοντες χρησιμοι για θεραπεια πονου | |
DE60030107D1 (de) | Vitamin-d derivate zur behandlung des systemischen lupus erythematodes | |
IL192100A0 (en) | Use of benzo-fused heterocycle sulfamide derivatives for the treatment of pain | |
DE60128540D1 (de) | Verwendung von relaxin zur behandlung von durch gefässverengung bedingten erkrankungen | |
ATE300289T1 (de) | Verwendung von (deaminohydroxy)toremifene zur behandlung von vaginalen trockenheit oder sexuellen störung während und nach der menopause | |
BR9809678A (pt) | Derivados de triptolìdeo úteis no tratamento de doenças autoimunes | |
DE69808131D1 (de) | Verfahren zur vorbeugung und behandlung des myokardialen stunnings | |
EP1419129A4 (de) | Verwendung von verzweigtkettigen fettsäuren und ihrer derivate zur schmerzbehandlung | |
ATE293972T1 (de) | Behandlung von chronischen schmerzen | |
BR0315374A (pt) | Compostos orgânicos | |
DE60024408D1 (de) | Verwendung von trizyklischen antidepressiva zur behandlung von kopfschmerzen | |
DE60121978D1 (de) | 7-CHLOR-4-HYDROXY-2-(2-PYRIDYLETHYL)-1,2,5,10-TETRAHYDROPYRIDAZINOi4,5-BöCHINOLIN-1,10-DIONE UND IHRE VERWENDUNG ZUR BEHANDLUNG VON SCHMERZEN | |
EP1048294A3 (de) | Verwendung eines Nitratvasodilators allein oder in Kombination mit Capsaicin zur Behandlung von Schmerz | |
ECSP045244A (es) | Composiciones farmaceuticas | |
ATE254919T1 (de) | Verwendung von penciclovir zur behandlung von menschlichem herpes virus-8 | |
DE69635282D1 (de) | Behandlung der exzessiven aggressivität mit olanzapine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |